Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Risperdal Consta in Schizophrenia
NCT00216671Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of risperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Nov 2005; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00216671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216671.